Sustained in vivo signaling by long-lived IL-2 induces prolonged increases of regulatory T cells.
about
Establishment and Maintenance of the Human Naïve CD4+ T-Cell CompartmentRegulatory T Cell Responses in Participants with Type 1 Diabetes after a Single Dose of Interleukin-2: A Non-Randomised, Open Label, Adaptive Dose-Finding TrialAutoimmunity in 2015.Potent antitumour activity of interleukin-2-Fc fusion proteins requires Fc-mediated depletion of regulatory T-cellsIL-2 promotes early Treg reconstitution after allogeneic hematopoietic cell transplantation.Manipulation of Innate and Adaptive Immunity through Cancer Vaccines.Progress and challenges for treating Type 1 diabetes.Molecular checkpoints controlling natural killer cell activation and their modulation for cancer immunotherapy.The Inflammatory Response in Psoriasis: a Comprehensive Review.Acute myeloid leukemia targets for bispecific antibodies.Cyclosporine restores hematopoietic function by compensating for decreased Tregs in patients with pure red cell aplasia and acquired aplastic anemia.Human naïve regulatory T-cells feature high steady-state turnover and are maintained by IL-7Prophylactic Interleukin-2 Treatment Prevents Fetal Gut Inflammation and Injury in an Ovine Model of Chorioamnionitis.Triplebody Mediates Increased Anti-Leukemic Reactivity of IL-2 Activated Donor Natural Killer (NK) Cells and Impairs Viability of Their CD33-Expressing NK Subset.IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced FunctionIn Vitro Induction of Human Regulatory T Cells Using Conditions of Low Tryptophan Plus Kynurenines.A phase I clinical study to evaluate safety of orally administered, genetically engineered Salmonella enterica serovar Typhimurium for canine osteosarcoma.Isogenic Cellular Systems Model the Impact of Genetic Risk Variants in the Pathogenesis of Type 1 Diabetes.Scanning the Immunopathogenesis of Psoriasis.CD11a/ICAM-1 blockade combined with IL-2 targeting therapy causes a paradoxical acceleration of type 1 diabetes.Robust Ki67 detection in human blood by flow cytometry for clinical studies.Reduced interleukin-2 responsiveness impairs the ability of Treg cells to compete for IL-2 in nonobese diabetic mice.Targeting Regulatory T Cells to Treat Patients With Systemic Lupus Erythematosus.
P2860
Q28080000-FA0DD658-C8C8-422F-B149-10C45F9DDE49Q28554636-1B3F00E9-21EB-4D63-8873-416773841F90Q30248983-767470A3-30A0-463B-A47D-50DE0B82DE87Q33705698-BBDE3E3E-703D-4C9E-A08F-2443298AFDA1Q33816022-44E81A42-5539-4BA3-B0CB-E64993AD3BA5Q34552791-4A1F8761-B28B-440B-93FE-379F90B64EC4Q36995389-2DFFE2C2-566F-49FB-BABE-571CE43C95CBQ37739485-C630BF92-8D27-47CB-85AB-5B9F775B77F2Q38792930-0176FF3A-995F-4C40-8C5F-0261AFA4E090Q39117761-CE0C262E-DCE5-4A3C-ADAC-9D2398CE1518Q39927825-3B24D33B-0E8D-4D8D-B638-20EE46D08C0DQ39972202-0E07130F-F34D-4087-A959-BC182ADA308EQ40909567-3050BEB4-CB6B-4FCF-BC8B-2A5EA9D5486FQ41699529-94A9594A-94FA-42C3-9C34-2ED4127EB2C9Q42134875-381F8142-4D1C-49CF-83A7-5101EDD69DFAQ42509292-9CCDCFDB-A644-47F1-A99E-AD97AE3B1533Q42657781-9AFCB4D3-32A9-474F-85A8-26F3FB4D3216Q45818945-4A3CA502-C6F3-4F65-94D2-0AC0DC17AEEDQ48278167-5D8FB0C3-6E3D-4613-98F0-286A15CF32BDQ48282629-BB197972-BAE4-455F-8B18-ED42B92D04E5Q51347719-24075ED0-8C59-4C15-8442-2C94A2DB23C2Q53210404-C618A1EE-14EE-4062-BBF9-0A628592A92CQ55096330-BE0171CF-D150-4DCE-ACF5-82E962AE71C6
P2860
Sustained in vivo signaling by long-lived IL-2 induces prolonged increases of regulatory T cells.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Sustained in vivo signaling by ...... creases of regulatory T cells.
@ast
Sustained in vivo signaling by ...... creases of regulatory T cells.
@en
Sustained in vivo signaling by ...... creases of regulatory T cells.
@nl
type
label
Sustained in vivo signaling by ...... creases of regulatory T cells.
@ast
Sustained in vivo signaling by ...... creases of regulatory T cells.
@en
Sustained in vivo signaling by ...... creases of regulatory T cells.
@nl
prefLabel
Sustained in vivo signaling by ...... creases of regulatory T cells.
@ast
Sustained in vivo signaling by ...... creases of regulatory T cells.
@en
Sustained in vivo signaling by ...... creases of regulatory T cells.
@nl
P2093
P2860
P1476
Sustained in vivo signaling by ...... ncreases of regulatory T cells
@en
P2093
Charles J M Bell
Christian Klein
Ekkehard Moessner
Inja Waldhauer
Laurence B Peterson
Linda S Wicker
Marcin L Pekalski
Oliver Ast
Pablo Umana
P2860
P356
10.1016/J.JAUT.2014.10.002
P577
2014-10-30T00:00:00Z